https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55040 Thu 04 Apr 2024 13:51:52 AEDT ]]> Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42359 Mon 22 Aug 2022 14:08:27 AEST ]]> PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48482 Mon 20 Mar 2023 10:27:49 AEDT ]]> ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53140 Fri 17 Nov 2023 11:42:18 AEDT ]]>